Topics that will be discussed during CT-Cann2023
- Phytocannabinoid study – strains, chemovars, entourage and molecules
- Pharamacokinetics and pharmacodynamics of cannabinoids
- How can we predict the response to cannabinoid treatment?
- Clinical cannabinoid therapy across medical specialties such as Pain, Gastroenterology, Palliative Care, Psychiatry and Neurology
- New and emerging designs for cannabis clinical trials
- Clinical Registries from around the globe – what can we learn?
- How to interpret clinical, observational and epidemiological studies: findings, interpretations, applicability
- Regulatory, licensing, and legal considerations – effects on clinical availability and industry development
- Cannabinoid trial best conduct including GCP and site training
- Assessing safety and adverse events of cannabinoid medications
- National and international guidelines
- Where is the industry heading? A discussion with leaders in the field
- Translating Current Evidence to Clinical Practice – meet the expert roundtables, open Q&A and practical tools for prescribers